{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:49:54Z","timestamp":1762530594376,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T00:00:00Z","timestamp":1682985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA046592"],"award-info":[{"award-number":["P30 CA046592"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.adro.2023.101266","type":"journal-article","created":{"date-parts":[[2023,5,5]],"date-time":"2023-05-05T22:03:11Z","timestamp":1683324191000},"page":"101266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5301-6223","authenticated-orcid":false,"given":"Rishi","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeline R.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott W.","family":"Hadley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaibhav","family":"Sahai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filip","family":"Bednar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph R.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore S.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle C.","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2023.101266_bib0001","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1634\/theoncologist.2015-0316","article-title":"Contemporary management of borderline resectable and locally advanced unresectable pancreatic cancer","volume":"21","author":"Shaib","year":"2016","journal-title":"Oncologist"},{"key":"10.1016\/j.adro.2023.101266_bib0002","doi-asserted-by":"crossref","first-page":"28","DOI":"10.21037\/cco.2017.06.12","article-title":"Radiation therapy in the management of pancreatic adenocarcinoma: Review of current evidence and future opportunities","volume":"6","author":"Robin","year":"2017","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.adro.2023.101266_bib0003","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1001\/jama.2016.4324","article-title":"Effect of chemoradiotherapy versus chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib the LAP07 randomized clinical trial","volume":"315","author":"Hammel","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.adro.2023.101266_bib0004","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4143\/crt.2017.105","article-title":"The role of consolidation chemoradiotherapy in locally advanced pancreatic cancer receiving chemotherapy: An updated systematic review and meta-analysis","volume":"50","author":"Chang","year":"2018","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.adro.2023.101266_bib0005","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1200\/JCO.19.02274","article-title":"Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: Results of the Dutch randomized phase III PREOPANC trial","volume":"38","author":"Versteijne","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2023.101266_bib0006","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3748\/wjg.v19.i2.185","article-title":"Gastrointestinal radiation injury: Symptoms, risk factors and mechanisms","volume":"19","author":"Shadad","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.adro.2023.101266_bib0007","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1016\/j.ijrobp.2012.07.835","article-title":"Clinical outcomes for gastric cancer following adjuvant chemoradiation utilizing intensity modulated radiation therapy","volume":"84","author":"Liu","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101266_bib0008","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.prro.2015.09.006","article-title":"Intensity modulated radiation therapy reduces gastrointestinal toxicity in locally advanced pancreas cancer","volume":"6","author":"Prasad","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101266_bib0009","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13014-018-1063-5","article-title":"Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer","volume":"13","author":"Goto","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2023.101266_bib0010","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3747\/co.23.2771","article-title":"Dosimetric and clinical toxicity comparison of critical organ preservation with three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, and RapidArc for the treatment of locally advanced cancer of the pancreatic head","volume":"23","author":"Jin","year":"2016","journal-title":"Curr Oncol"},{"key":"10.1016\/j.adro.2023.101266_bib0011","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ijrobp.2011.12.026","article-title":"Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy","volume":"84","author":"Nakamura","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101266_bib0012","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.meddos.2010.08.003","article-title":"A comparison of helical intensity-modulated radiotherapy, intensity-modulated radiotherapy, and 3D-conformal radiation therapy for pancreatic cancer","volume":"36","author":"Poppe","year":"2012","journal-title":"Med Dosim"},{"key":"10.1016\/j.adro.2023.101266_bib0013","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3857\/roj.2014.32.3.103","article-title":"Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials","volume":"32","author":"Kim","year":"2014","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.adro.2023.101266_bib0014","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/gut.42.4.555","article-title":"Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction","volume":"42","author":"Ballinger","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.adro.2023.101266_bib0015","doi-asserted-by":"crossref","first-page":"40184","DOI":"10.1038\/srep40184","article-title":"In vivo response of AZ31 alloy as biliary stents: A 6 months evaluation in rabbits","volume":"7","author":"Liu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.adro.2023.101266_bib0016","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.gie.2011.02.001","article-title":"Esophageal cancer patients undergoing external beam radiation after placement of self-expandable metal stents: Is there a risk of radiation dose enhancement?","volume":"73","author":"Chen","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.adro.2023.101266_bib0017","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1120\/jacmp.v14i4.4218","article-title":"Self-expanding stent effects on radiation dosimetry in esophageal cancer","volume":"14","author":"Francis","year":"2013","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.adro.2023.101266_bib0018","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0360-3016(02)03803-8","article-title":"Radiotherapy dose perturbation of metallic esophageal stents","volume":"54","author":"Li","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2023.101266_bib0019","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0016-5107(04)00855-7","article-title":"Comparison of radiation dosimetry effects of metallic biliary stents","volume":"59","author":"Darwin","year":"2004","journal-title":"Gastrointest Endosc"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109423000957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109423000957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:43:54Z","timestamp":1762530234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109423000957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2452109423000957"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2023.101266","relation":{},"ISSN":["2452-1094"],"issn-type":[{"type":"print","value":"2452-1094"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2023.101266","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101266"}}